Fusion Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Fusion Capital's AMGN Position: Q1 2026 in Review
Fusion Capital reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $29.6K and leaving 25,979 shares worth $9.14M. The position accounts for 2.47% of the portfolio, ranked #17.
Fusion Capital first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Fusion Capital held 25,979 shares of Amgen worth $9.14M as of Q1 2026.
- Fusion Capital sold 83 Amgen shares in Q1 2026, an estimated $29.6K.
- Amgen made up 2.47% of Fusion Capital's portfolio in Q1 2026, its #17 holding.
- Fusion Capital first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Fusion Capital's 13F filing for Q1 2026, filed 13 May 2026.